Why now

People picked up the story on June 28 after NYU Langone had already published the hospital-confirmed version, giving this a rare double window: primary medical confirmation plus mainstream human-interest reach. The story also has unusually clean emotional timing: a father, a baby, a rare metabolic disorder, a birthday surgery, and a nine-month recovery update. That makes it immediately publishable as Good News Medicine, but the breakthrough is not a new therapy. The timely angle is living-donor access and the public reminder that a transplant can turn a fatal metabolic trajectory into a survivable one when the right team, donor, and timing align.